Voiding diary predicts the therapeutic effects on primary monosymptomatic nocturnal enuresis
10.3969/j.issn.1009-8291.2023.04.003
- VernacularTitle:排尿日记对醋酸去氨加压素和遗尿报警器治疗原发性单症状夜遗尿症疗效的预测作用
- Author:
Shuai LI
1
;
Shuai YANG
1
;
Zhaokai ZHOU
1
;
Yanping ZHANG
1
;
Jing YANG
1
;
Guoxian ZHANG
2
;
Qingwei WANG
1
,
3
;
Wei LU
4
;
Jianguo WEN
1
,
3
Author Information
1. Henan Joint International Pediatric Urodynamic Laboratory of the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052
2. Department of Urology, First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052
3. Department of Urology, First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052
4. Department of Urology, Xinyang Central Hospital, Xinyang Hospital Affiliated to Zhengzhou University, Xinyang 464099, China
- Publication Type:Journal Article
- Keywords:
children;
enuresis;
desmopressin;
enuresis alarm;
treatment
- From:
Journal of Modern Urology
2023;28(4):283-286
- CountryChina
- Language:Chinese
-
Abstract:
【Objective】 To investigate the possibility of using voiding diary (VD) to predict desmopressin diacetate arginine vasopressin (DDAVP) and enuresis alarm (EA) in the treatment of primary monosymptomatic nocturnal enuresis (PMNE). 【Methods】 A total of 100 children (aged 6 to 14 years) with PMNE treated during Jan.2018 and Oct.2022 were involved. Bladder type was classified with two-week VD. Pseudo-randomization was performed using the Danish REDCap system to group patients into the randomized group and VD group. All patients were treated for 8 weeks. 【Results】 A total of 82 cases met the inclusive criteria. The effective rate was 82.50% (33/40) and 59.52% (25/42) in the VD and randomized groups, respectively, with significant difference (χ2=5.224, P=0.022). In the randomized group, if VD was not considered, the effective rate in the DDAVP and EA subgroups was 81.82% (18/22) and 25.00% (5/20), respectively, with significant difference (χ2=13.625, P=0.000). 【Conclusion】 VD can predict the therapeutic effects of PMNE. It is necessary to record VD for two weeks before selecting appropriate treatment methods. For patients who choose treatment without reference to VD, DDAVP shows better response than EA, but the recurrence rate after discontinuation of treatment requires further follow-up.
